NDC 17033-282 - Vetromax
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 17033-282
- Package NDCs from labels
- 17033-282-75, 17033-282-15
- Manufacturer
- Dechra Veterinary Products | Fougera Pharmaceuticals Inc.
- Effective date
- 2021-10-21
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Vetromax - Dechra Veterinary Products | Fougera Pharmaceuticals Inc. | Dechra Veterinary Products | Fougera Pharmaceuticals Inc. | 2021-10-21 | PRESCRIPTION ANIMAL DRUG LABEL |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| TM-Clotrimazole | CLOTRIMAZOLE 1% | Singular Dreamer, Ltd dba True Marker | d6a9755a-9ed1-4e7d-8e73-25c169d6c6b1 | 2025-10-06 | Warnings | G07GZ97H65 |
| BETAMETHASONE VALERATE | BETAMETHASONE VALERATE | Sun Pharmaceutical Industries, Inc. | 3c85be0f-2731-44f1-a18e-d3852d54846f | 2025-10-02 | Adverse reactions | 9IFA5XM7R2 |
| Leader Ready to Use Mineral Oil Laxative | MINERAL OIL | Cardinal Health | b8494d02-8a7d-47b4-80b0-b8ab51b625fd | 2025-09-29 | Warnings | T5L8T28FGP |
| LEADER ATHLETES FOOT CLOTRIMAZOLE | CLOTRIMAZOLE | LEADER | dcea717b-b097-4a40-8e38-05212731a7ef | 2025-09-29 | Warnings | G07GZ97H65 |
| Betamethasone valerate | BETAMETHASONE VALERATE | Alembic Pharmaceuticals Limited | 75d70e76-023c-4a00-954d-79a697bed80f | 2025-09-25 | Adverse reactions | 9IFA5XM7R2 |
| RUGBY ANTIFUNGAL CLOTRIMAZOLE | CLOTRIMAZOLE | Rugby Laboratories | 0b32a369-ea1c-4cb8-8ea1-07bba8f16b72 | 2025-09-16 | Warnings | G07GZ97H65 |
| Clotrimazole | CLOTRIMAZOLE | Sun Pharmaceutical Industries, Inc. | 77883cfd-f13c-40cb-88b2-8f777e1cdce9 | 2025-09-10 | Warnings, Adverse reactions | G07GZ97H65 |
| Clotrimazole and Betamethasone Dipropionate | CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE | Bryant Ranch Prepack | 153fed41-6662-4ca9-802f-84b44dcb65e9 | 2025-09-09 | Warnings, Adverse reactions | G07GZ97H65 |
| Clotrimazole | CLOTRIMAZOLE | Strategic Sourcing Services LLC | de3b6b64-dfa5-4abd-ba43-4ab59b4c2284 | 2025-09-09 | Warnings | G07GZ97H65 |
| ANTIFUNGAL | CLOTRIMAZOLE | Encube Ethicals, Inc. | afbc28f8-bb76-424d-9d73-136e6c283ead | 2025-09-04 | Warnings | G07GZ97H65 |
| femmesil Ultra Therapy | CLOTRIMAZOLE | Aidance Scientific, Inc. | 3d36794a-07d0-860c-e063-6294a90a6e8f | 2025-08-25 | Warnings | G07GZ97H65 |
| Clotrimazole | CLOTRIMAZOLE | TRIFECTA PHARMACEUTICALS USA LLC | 6b74d405-42d6-4c46-ba78-3007d1e8ffb8 | 2025-08-23 | Warnings | G07GZ97H65 |
| Exchange Select Hemorrhoidal | MINERAL OIL, PETROLATUM, PHENYLEPHRINE HCL | Army & Air Force Exchange Service | 6c32af3e-5b60-4e3e-95c2-ada37a7d3b2a | 2025-08-22 | Warnings | T5L8T28FGP |
| Hemorrhoidal | MINERAL OIL, PETROLATUM, PHENYLEPHRINE HCL | Padagis Israel Pharmaceuticals Ltd | 43826c68-0a20-460d-a7b5-f3e12395a7d0 | 2025-08-22 | Warnings | T5L8T28FGP |
| Hemorrhoidal | MINERAL OIL, PETROLATUM, PHENYLEPHRINE HCL | Publix Super Markets Inc | 7b360d3b-fb2b-4f35-a04d-203dd352933d | 2025-08-19 | Warnings | T5L8T28FGP |
| Good Sense Hemorrhoidal | MINERAL OIL, PETROLATUM, PHENYLEPHRINE HCL | L. Perrigo Company | 2492ee1b-01f1-46e7-8790-b6ebc48f2aff | 2025-08-19 | Warnings | T5L8T28FGP |
| Clotrimazole | CLOTRIMAZOLE | AvPAK | 3ca3b475-7b69-442a-e063-6294a90a7b3f | 2025-08-18 | Warnings | G07GZ97H65 |
| SupreH Ringworm Treatment Balm | SUPREH RINGWORM TREATMENT BALM | Shenzhen Xinxin Yunhai Technology Co., Ltd. | 3c77222b-d92e-84b0-e063-6294a90aadd7 | 2025-08-16 | Warnings | G07GZ97H65 |
| DG Health Hemorrhoidal | MINERAL OIL, PETROLATUM, PHENYLEPHRINE HCL | Dolgencorp, LLC | d9f12a34-7bd1-4ba5-b34b-1b641f58271a | 2025-08-12 | Warnings | T5L8T28FGP |
| Stye | MINERAL OIL AND PETROLATUM | Insight Pharmaceuticals LLC | f7eb8466-d8ea-4833-9bed-244ead38a3bf | 2025-08-11 | Warnings | T5L8T28FGP |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.